Pacific Biosciences of California, Inc. PACB
2.36 USD +0.10 (+4.66%)
At closeNov 10, 2026, 4:46 AM EST
2.37 +0.01 +0.42%
Pre-market · Nov 10, 4:46 AM ET
2.16 Day range 2.43
1.07 52-week range 3.44
- YTD
- +26.20%
- 1 year
- +34.09%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 160.00M | 154.01M | 200.52M | 128.30M | 130.51M | |
| 45.78M | 37.28M | 52.78M | 49.03M | 58.86M | |
| -572.56M | -475.16M | -319.41M | -304.82M | -209.29M | |
| -546.38M | -309.85M | -306.74M | -314.25M | -181.22M | |
| -1.82 | -1.59 | -1.21 | -1.40 | -0.89 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 63.73M | 56.06M | 180.21M | 325.39M | 461.23M | |
| 784.08M | 1.26B | 1.75B | 1.77B | 2.01B | |
| 778.73M | 753.85M | 1.04B | 1.20B | 1.22B | |
| 702.42M | 672.43M | 933.44M | 946.64M | 953.75M | |
| 5.35M | 506.59M | 701.30M | 562.90M | 790.99M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -111.21M | -206.06M | -259.17M | -263.21M | -111.18M | |
| 115.45M | 124.00M | 4.60M | 116.08M | -678.53M | |
| 3.43M | 7.70M | 110.73M | 11.23M | 1.17B | |
| -2.71M | -6.19M | -8.84M | -16.75M | -5.93M |